Saturday, 3 October 2026
Global markets, trading & world business — for professional traders
Markets
Private Trade News venue-risk note (2026-10-03): The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the… Primary source: original at Nasdaq (nasdaq.com).
MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57
The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the prior estimate of $3.06 dated January 11, 2026. These figures represent aggregate analyst targets collected by Fintel, rat